X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (115) 115
index medicus (103) 103
rheumatology (90) 90
male (81) 81
female (80) 80
middle aged (75) 75
aged (61) 61
adult (58) 58
scleroderma (49) 49
systemic sclerosis (49) 49
rheumatoid arthritis (42) 42
arthritis (33) 33
arthritis, rheumatoid - drug therapy (32) 32
disease (29) 29
severity of illness index (28) 28
classification (26) 26
cohort studies (25) 25
antirheumatic agents - therapeutic use (24) 24
systemic scleroderma (23) 23
prognosis (21) 21
risk factors (21) 21
immunology (20) 20
treatment outcome (20) 20
analysis (19) 19
australia (19) 19
rheumatoid factor (19) 19
research article (17) 17
scleroderma, systemic - complications (17) 17
criteria (16) 16
diagnosis (16) 16
mortality (16) 16
prevalence (16) 16
rheumatoid-arthritis (16) 16
care and treatment (14) 14
scleroderma, systemic - diagnosis (14) 14
time factors (14) 14
abridged index medicus (13) 13
immunology and allergy (13) 13
inflammation (13) 13
patients (13) 13
pulmonary hypertension (13) 13
remission induction (13) 13
american-college (12) 12
arthritis, rheumatoid - diagnosis (12) 12
disease progression (12) 12
double-blind (12) 12
medicine, general & internal (12) 12
modifying antirheumatic drugs (12) 12
therapy (12) 12
aged, 80 and over (11) 11
association (11) 11
autoantibodies (11) 11
drug therapy, combination (11) 11
longitudinal studies (11) 11
methotrexate (11) 11
predictive value of tests (11) 11
quality-of-life (11) 11
research (11) 11
biomarkers - blood (10) 10
disease-activity (10) 10
follow-up studies (10) 10
health risk assessment (10) 10
methotrexate - therapeutic use (10) 10
remission (10) 10
antirheumatic agents - administration & dosage (9) 9
cross-sectional studies (9) 9
hypertension, pulmonary - etiology (9) 9
leflunomide (9) 9
logistic models (9) 9
medical research (9) 9
pharmacology & pharmacy (9) 9
prospective studies (9) 9
quality of life (9) 9
scleroderma, systemic - blood (9) 9
scleroderma, systemic - immunology (9) 9
scleroderma, systemic - mortality (9) 9
sulfasalazine - therapeutic use (9) 9
clinical medicine (8) 8
drug therapy (8) 8
epidemiology (8) 8
fibrosis (8) 8
genetic aspects (8) 8
hydroxychloroquine - therapeutic use (8) 8
hypertension (8) 8
metaanalysis (8) 8
placebo (8) 8
pulmonary arterial hypertension (8) 8
systemic-sclerosis (8) 8
antirheumatic agents - adverse effects (7) 7
arthritis, rheumatoid - blood (7) 7
arthritis, rheumatoid - physiopathology (7) 7
australia - epidemiology (7) 7
autoantibodies - immunology (7) 7
case-control studies (7) 7
clinical trials (7) 7
fatty acids (7) 7
fish oils (7) 7
health aspects (7) 7
health status (7) 7
lung diseases (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 2018, Volume 13, Issue 2, p. e0192704
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2017, Volume 12, Issue 9, p. e0183928
...Author(s): Alice M. Walsh 1, Mihir D. Wechalekar 2,3, Yanxia Guo 1, Xuefeng Yin 1, Helen Weedon 3, Susanna M. Proudman 4,5, Malcolm D. Smith 3,*, Sunil Nagpal... 
TARGET | THERAPY | MULTIDISCIPLINARY SCIENCES | DISEASE | CSF | METHOTREXATE | MEMBRANES | ASSOCIATION | PLASMA-CELLS | Hydroxychloroquine - therapeutic use | Humans | Middle Aged | Transcriptome | Male | Synovial Membrane - drug effects | Methotrexate - therapeutic use | Case-Control Studies | Arthroscopy | Arthritis, Rheumatoid - drug therapy | T-Lymphocytes - drug effects | Adult | Female | Cell Differentiation | Drug Therapy, Combination | Principal Component Analysis | Antirheumatic Agents - therapeutic use | Sulfasalazine - therapeutic use | Down-Regulation | Remission Induction | Synovial Membrane - metabolism | Sequence Analysis, RNA | T-Lymphocytes - cytology | Biopsy | Lymphocyte Activation - drug effects | Aged | Plasma Cells - cytology | Hydroxychloroquine | Analysis | Rheumatoid arthritis | Sulfasalazine | Dosage and administration | Cell differentiation | Methotrexate | Drug therapy | Risk factors | Drugs | Target recognition | Transcription | Genes | Differentiation (biology) | Lymphocytes T | Activation | Genomes | Arthritis | Kinases | Tissues | Synovium | Gene sequencing | Biological effects | Cell activation | Immunology | Pathways | Remission | Tumor necrosis factor-TNF | Rheumatism | Cytokines | Research & development--R&D | Rheumatology | Rheumatic diseases | Inflammation | Gene expression | Ribonucleic acid--RNA | Patients | Genetic engineering | Autoimmune diseases | RNA | Research & development | Ribonucleic acid | R&D
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 05/2017, Volume 69, Issue 5, pp. 1067 - 1077
Journal Article
Journal Article
Seminars in Arthritis and Rheumatism, ISSN 0049-0172, 2016, Volume 46, Issue 3, pp. 344 - 349
Journal Article
Journal Article
Arthritis research & therapy, ISSN 1478-6362, 2019, Volume 21, Issue 1, pp. 299 - 12
Background: To determine the frequency and clinical characteristics of systemic sclerosis-related digital ulcers, and associated direct health care costs,... 
Digital ulceration | Economic burden | Systemic sclerosis | COHORT | QUALITY-OF-LIFE | RHEUMATOLOGY | Scleroderma | VASCULOPATHY | MANIFESTATIONS | Hypertension | Fecal incontinence | Health care policy | Arthritis | RNA polymerase | Patients | Epidemiology | Esophagus | Antibiotics | Medical prognosis | Ulcers | Standard deviation | Ambulatory care
Journal Article